Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 5 15 SULFITE FREE IN DEXTROSE 15 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 5 15 SULFITE FREE IN DEXTROSE 15 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER vs PERIKABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amino acids provide substrates for protein synthesis and nitrogen balance; dextrose provides caloric support. Electrolytes maintain acid-base and fluid balance.
Perikabiven provides a balanced mixture of amino acids, electrolytes, dextrose, and lipids for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, dextrose provides glucose for energy, and lipids supply essential fatty acids and a concentrated energy source. Electrolytes maintain osmotic balance and support biochemical reactions.
Intravenous infusion. Dose individualized based on protein and calorie requirements. Typical adult dose: 500-2000 mL/day, providing 5% amino acids (50 g/L) and 15% dextrose (150 g/L). Infusion rate not to exceed 0.1 g/kg/hour of amino acids.
Intravenous administration: usual adult dose is 1.5 to 2.0 g amino acids per kg per day, corresponding to 25-30 mL/kg/day of Perikabiven, with a maximum infusion rate of 2.5 mL/kg/hour.
None Documented
None Documented
Not applicable as a composite; individual amino acids: 0.5–2 h, dextrose: 1.5–2.5 h. Clinical context: continuous infusion reaches steady state within 4–6 h.
Amino acids: ~0.5-1 hour (rapid clearance due to metabolic incorporation and urinary elimination). Lipids: terminal elimination half-life of ~30 minutes to 1.5 hours for triglycerides, with longer half-life for essential fatty acids (days to weeks due to incorporation into cell membranes). Clinical context: rapid clearance from plasma with continuous infusion.
Renal excretion of amino acids and dextrose metabolites; 100% eliminated via kidneys as urea, CO2, and water. Biliary/fecal negligible.
Renal (primarily as ammonium and urea) and biliary (fecal loss of unabsorbed lipids). The amino acids, dextrose, and electrolytes are eliminated via renal excretion; lipids are metabolized and eliminated as CO2 and water. Approximately 20-30% of the lipid dose is excreted renally as metabolites, with <5% excreted unchanged.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition